V2 Swan Robotics
Swan EndoSurgical (often referred to as Swan Robotics in context) is a newly co-founded startup dedicated to developing endoluminal surgical robotic solutions to improve gastrointestinal (GI) patient care globally. The company focuses on creating a novel robotic system for earlier, safer, and more effective treatment of lesions or tumors in the GI tract relative to current therapeutic options. Co-founded by Revival Healthcare Capital and Olympus Corporation, Swan aims to revolutionize less invasive therapeutic treatments through advanced medical robotics.
💡Notable Achievement: Swan EndoSurgical was co-founded with a joint investment of up to $458 million from Revival Healthcare Capital and Olympus Corporation, marking a significant build-to-buy agreement in the robotic surgery and MedTech sector.
V2 Swan Robotics Robots & Products
Showing 0 of 0 total models
Frequently Asked Questions
Expert answers about V2 Swan Robotics
Q:What is Swan EndoSurgical's primary mission?
A: Swan EndoSurgical's primary mission is to develop endoluminal surgical robotic solutions to improve patient care globally, specifically targeting gastrointestinal (GI) treatments.
Q:Who are the co-founders of Swan EndoSurgical?
A: Swan EndoSurgical was co-founded by Revival Healthcare Capital and Olympus Corporation, two major players in the investment and healthcare technology sectors.
Q:What type of robotics does Swan EndoSurgical develop?
A: The company develops endoluminal surgical robotics, which are designed for less invasive therapeutic treatments of lesions or tumors in the GI tract.
Q:How much funding has Swan EndoSurgical received?
A: Swan EndoSurgical has a joint investment of up to $458 million from its co-founders, with an initial investment of at least $65 million from Olympus.
Q:Where is Swan EndoSurgical headquartered?
A: Swan EndoSurgical is headquartered in Canton, Massachusetts, USA, with an additional location in Cambridge, United Kingdom.
Q:What is the target market for Swan's robotic systems?
A: The target market includes gastrointestinal (GI) patient care, colorectal surgery, and the treatment of lesions or tumors in the GI tract.
Q:Is Swan EndoSurgical a public or private company?
A: Swan EndoSurgical is a privately held company, currently in the startup phase with a seed funding status.
Q:What is the significance of the Olympus-Swan deal?
A: The deal represents a 'build-to-buy' model in MedTech, allowing Olympus to expand into high-value GI interventions while reducing the risk of acquiring early-stage technologies.
Q:Does Swan EndoSurgical have a leadership team?
A: Yes, Olympus stated that Swan EndoSurgical has already assembled an experienced leadership team to drive the development of its robotic platform.
Q:How can I contact Swan EndoSurgical?
A: You can contact Swan EndoSurgical via email at info@swansurg.com or visit their official website at www.swanendosurgical.com for more information.
💡Expert Info: Compiled from verified manufacturer data and official sources. Data verified directly from official channels. For current specs, contact V2 Swan Robotics directly.